$550,000 grant supports VT researchers to study the effects of changing food spending patterns

After a long day, there’s the age-old question of do we eat out or stay in? Over the last decade, that answer has increasingly shifted to eating out.

Vita 34 significantly increases earnings and operating cash flow in the first quarter – Biotech Investments

EQS-News: Vita 34 AG / Key word(s): Quarterly / Interim Statement Vita 34 significantly increases earnings and operating cash flow in the first quarter 31.05.2024

June 1, 2024

Novel deep learning model to assess Alzheimer’s disease progression risk

Patterns in the Alzheimer’s disease (AD) trajectory using Mendelian randomization (MR) and deep learning (DL).

October 3, 2023

Risk adjusted net present value: What is the current valuation of Novo Nordisk’s NN-9931?

NN-9931 is a recombinant peptide commercialized by Novo Nordisk, with a leading Phase III program in Metabolic Dysfunction-Associated Steatohepatitis (MASH).

April 17, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.